Company / Free Cash Flow
Neogen Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$24.7M
FY2025
5-year range
-$76.2M / $61.8M
FY2021-FY2025
Trend
+46.6%
vs FY2024
Sector context
#127 of 151
Health Care
What the data says
Neogen's free cash flow of -$25M is lower than 84% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from -$76M in FY2023 to $62M in FY2022.
Based on SEC 10-K filings.
-$25M in FY2025.
Improved from -$76M to -$25M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 151This company -$24.7M Sector average $779.8M
▼
-103.2% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 46.6% year-over-year.
- Ranks #127 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2022.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$24.7M | +46.6% |
| FY2024 | -$46.4M | +39.1% |
| FY2023 | -$76.2M | -223.2% |
| FY2022 | $61.8M | +25.7% |
| FY2021 | $49.2M | +2.1% |
| FY2020 | $48.2M | +5.4% |
| FY2019 | $45.7M | +116.5% |
| FY2018 | $21.1M | -38.2% |
| FY2017 | $34.2M | +237.5% |
| FY2016 | $10.1M | -42.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026